Scientists have reported encouraging early findings from an experimental optogenetic therapy designed for people suffering from retinitis pigmentosa, a severe degenerative eye disease. Preliminary results suggest the treatment is safe and may help restore partial visual function. Researchers describe the development as a significant milestone in the effort to combat inherited blindness.
About the Author
